You are here

MK-1293

Could This Look-A-Like Drug Be Merck's Next Big Seller?

Motley Fool

Sat, 10/29/16 - 01:21 pm

Merck eyes US approval with positive data on Lantus copy

BioPharma Dive

Tue, 06/14/16 - 09:30 pm

Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When

Seeking Alpha

Fri, 12/26/14 - 10:18 pm

Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes

Yahoo

Mon, 02/10/14 - 09:14 am

Samsung Bioepis

insulin glargine